EVMN

Evommune, Inc. Common Stock (EVMN)

About Evommune, Inc. Common Stock (EVMN)

Evommune, Inc. is a clinical-stage biotechnology company. It engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pena, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Palo Alto, CA.

Details

Daily high
$10.82
Daily low
$10.50
Price at open
$10.66
52 Week High
$33.20
52 Week Low
$10.30
Market cap
382.5M
Dividend yield
-
Volume
388,920
Avg. volume
627,544
P/E ratio
-3.73

Evommune, Inc. Common Stock News

Details

Daily high
$10.82
Daily low
$10.50
Price at open
$10.66
52 Week High
$33.20
52 Week Low
$10.30
Market cap
382.5M
Dividend yield
-
Volume
388,920
Avg. volume
627,544
P/E ratio
-3.73